366 related articles for article (PubMed ID: 30088440)
1. Application of nanodiagnostics and nanotherapy to CNS diseases.
Zhang W; Wang W; Yu DX; Xiao Z; He Z
Nanomedicine (Lond); 2018 Sep; 13(18):2341-2371. PubMed ID: 30088440
[TBL] [Abstract][Full Text] [Related]
2. Applications of nanotechnology in drug delivery to the central nervous system.
Saeedi M; Eslamifar M; Khezri K; Dizaj SM
Biomed Pharmacother; 2019 Mar; 111():666-675. PubMed ID: 30611991
[TBL] [Abstract][Full Text] [Related]
3. Potential Gene Therapy Towards Treating Neurodegenerative Disea ses Employing Polymeric Nanosystems.
Bangde P; Atale S; Dey A; Pandit A; Dandekar P; Jain R
Curr Gene Ther; 2017; 17(2):170-183. PubMed ID: 28494742
[TBL] [Abstract][Full Text] [Related]
4. Nanotechnology-based drug delivery systems for targeting, imaging and diagnosis of neurodegenerative diseases.
Pehlivan SB
Pharm Res; 2013 Oct; 30(10):2499-511. PubMed ID: 23959851
[TBL] [Abstract][Full Text] [Related]
5. Advances in the treatment of neurodegenerative disorders employing nanoparticles.
Spuch C; Saida O; Navarro C
Recent Pat Drug Deliv Formul; 2012 Apr; 6(1):2-18. PubMed ID: 22272933
[TBL] [Abstract][Full Text] [Related]
6. Nanotechnology-based Targeting of Neurodegenerative Disorders: A Promising Tool for Efficient Delivery of Neuromedicines.
Rajpoot K
Curr Drug Targets; 2020; 21(8):819-836. PubMed ID: 31906836
[TBL] [Abstract][Full Text] [Related]
7. Nanotechnological applications for the treatment of neurodegenerative disorders.
Modi G; Pillay V; Choonara YE; Ndesendo VM; du Toit LC; Naidoo D
Prog Neurobiol; 2009 Aug; 88(4):272-85. PubMed ID: 19486920
[TBL] [Abstract][Full Text] [Related]
8. Nanotechnology-based Drug Delivery for Alzheimer's and Parkinson's Diseases.
Nguyen-Thi PT; Ho TT; Nguyen TT; Vo GV
Curr Drug Deliv; 2024; 21(7):917-931. PubMed ID: 37424345
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
10. Current insights on lipid nanocarrier-assisted drug delivery in the treatment of neurodegenerative diseases.
Teixeira MI; Lopes CM; Amaral MH; Costa PC
Eur J Pharm Biopharm; 2020 Apr; 149():192-217. PubMed ID: 31982574
[TBL] [Abstract][Full Text] [Related]
11. Application of modelling and nanotechnology-based approaches: The emergence of breakthroughs in theranostics of central nervous system disorders.
Hassanzadeh P; Atyabi F; Dinarvand R
Life Sci; 2017 Aug; 182():93-103. PubMed ID: 28583367
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's Disease and Parkinson's Disease: A Review of Current Treatment Adopting a Nanotechnology Approach.
Trompetero A; Gordillo A; Del Pilar MC; Cristina VM; Bustos Cruz RH
Curr Pharm Des; 2018; 24(1):22-45. PubMed ID: 28847307
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnological advances for the delivery of CNS therapeutics.
Wong HL; Wu XY; Bendayan R
Adv Drug Deliv Rev; 2012 May; 64(7):686-700. PubMed ID: 22100125
[TBL] [Abstract][Full Text] [Related]
14. Strategies of Engineering Nanoparticles for Treating Neurodegenerative Disorders.
Nguyen KT; Pham MN; Vo TV; Duan W; Tran PH; Tran TT
Curr Drug Metab; 2017; 18(9):786-797. PubMed ID: 28124594
[TBL] [Abstract][Full Text] [Related]
15. Drug Delivery Applications of Nanoparticles in the Spine.
Venugopal I; Mehta AI; Linninger AA
Methods Mol Biol; 2020; 2059():121-143. PubMed ID: 31435918
[TBL] [Abstract][Full Text] [Related]
16. Solid lipid nanoparticles as a drug delivery system for the treatment of neurodegenerative diseases.
Cacciatore I; Ciulla M; Fornasari E; Marinelli L; Di Stefano A
Expert Opin Drug Deliv; 2016 Aug; 13(8):1121-31. PubMed ID: 27073977
[TBL] [Abstract][Full Text] [Related]
17. Application of Therapeutic Nanoplatforms as a Potential Candidate for the Treatment of CNS Disorders: Challenges and Possibilities.
Sa P; Singh P; Dilnawaz F; Sahoo SK
Curr Pharm Des; 2022; 28(33):2742-2757. PubMed ID: 35909283
[TBL] [Abstract][Full Text] [Related]
18. Advances in nanomedicine for the treatment of Alzheimer's and Parkinson's diseases.
Hernando S; Gartziandia O; Herran E; Pedraz JL; Igartua M; Hernandez RM
Nanomedicine (Lond); 2016 May; 11(10):1267-85. PubMed ID: 27077453
[TBL] [Abstract][Full Text] [Related]
19. Advances in nanomedicines for diagnosis of central nervous system disorders.
Zhang X; Zhou J; Gu Z; Zhang H; Gong Q; Luo K
Biomaterials; 2021 Feb; 269():120492. PubMed ID: 33153757
[TBL] [Abstract][Full Text] [Related]
20. Nanobiomaterials' applications in neurodegenerative diseases.
Silva Adaya D; Aguirre-Cruz L; Guevara J; Ortiz-Islas E
J Biomater Appl; 2017 Feb; 31(7):953-984. PubMed ID: 28178902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
